Net Cash Provided by (Used in) Investing Activities in USD of PharmaCyte Biotech, Inc. from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2010 to Q2 2025.
  • PharmaCyte Biotech, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending July 31, 2025 was $0.000.
  • PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$7M, a 40% decline from 2023.
  • PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$5M.
  • PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $0.000.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)

PharmaCyte Biotech, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $0 +$7M May 1, 2025 Jul 31, 2025 10-Q 2025-09-15
Q2 2024 -$7M -$7M May 1, 2024 Jul 31, 2024 10-Q 2025-09-15
Q2 2023 $0 $0 May 1, 2023 Jul 31, 2023 10-Q 2024-09-17
Q2 2022 $0 $0 May 1, 2022 Jul 31, 2022 10-Q 2023-09-18
Q2 2021 $0 $0 May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q2 2020 $0 $0 May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q2 2019 $0 $0 May 1, 2019 Jul 31, 2019 10-Q 2020-09-11
Q2 2018 $0 $0 May 1, 2018 Jul 31, 2018 10-Q 2019-09-13
Q2 2017 $0 $0 May 1, 2017 Jul 31, 2017 10-Q 2018-09-12
Q2 2016 $0 May 1, 2016 Jul 31, 2016 10-Q 2017-09-13
Q2 2013 -$1.57M -$1.37M -701% May 1, 2013 Jul 31, 2013 10-Q 2013-09-16
Q2 2012 -$196K +$124K +38.8% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q2 2011 -$320K -$320K May 1, 2011 Jul 31, 2011 10-Q 2012-09-19
Q2 2010 $0 May 1, 2010 Jul 31, 2010 10-Q/A 2011-09-20

PharmaCyte Biotech, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$7M -$2M -40% May 1, 2024 Apr 30, 2025 10-K 2025-08-11
2023 -$5M -$5M May 1, 2023 Apr 30, 2024 10-K 2025-08-11
2022 $0 $0 May 1, 2022 Apr 30, 2023 10-K 2024-08-13
2021 $0 $0 May 1, 2021 Apr 30, 2022 10-K 2023-07-31
2020 $0 $0 May 1, 2020 Apr 30, 2021 10-K 2022-07-28
2019 $0 $0 May 1, 2019 Apr 30, 2020 10-K 2021-08-10
2018 $0 $0 May 1, 2018 Apr 30, 2019 10-K 2020-08-13
2017 $0 $0 May 1, 2017 Apr 30, 2018 10-K 2019-08-13
2016 $0 May 1, 2016 Apr 30, 2017 10-K 2018-07-20
2012 -$647K +$225K +25.8% May 1, 2012 Apr 30, 2013 10-K 2013-07-29
2011 -$872K May 1, 2011 Apr 30, 2012 10-K 2013-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.